Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
william.hinton@phc.ox.ac.uk

Telephone
+44 (0)1865 617285

ORCID
https://orcid.org/0000-0003-4927-0901

Research groups

Clinical Informatics and Health Outcomes Research Group

William Hinton

Research Fellow

Recent publications

Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study.
Journal article

de Lusignan S. et al, (2022), Diabetes therapy : research, treatment and education of diabetes and related disorders
Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people.
Journal article

Dambha-Miller H. et al, (2022), Fam Pract
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).
Journal article

Feher M. et al, (2022), JMIR Res Protoc, 11
Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study.
Journal article

Dambha-Miller H. et al, (2022), Fam Pract
The Effect of the COVID-19 Pandemic on Glycemic Monitoring and Other Processes of Care for Type 2 Diabetes: Protocol for a Retrospective Cohort Study
Journal article

Mathew M. et al, (2022), JMIR Research Protocols, 11

More publications